| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |